Genomics of diabetes mellitus type 1 and its late complications

Molekulyarnaya Biologiya

Volumn 38, Issue 1, 2004, Pages 150-164

  Nosikov, V V ^a  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; APOENZYME; APOPTOSIS INDUCING FACTOR; CATALASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; SUPEROXIDE; T LYMPHOCYTE ANTIGEN;

APOPTOSIS; CHROMOSOME NOR; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC RISK; GENOMICS; HLA SYSTEM; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSATELLITE MARKER; MITOCHONDRION; OXIDATIVE STRESS; REVIEW; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE DETECTION; HUMAN; RUSSIAN FEDERATION;

DIABETES MELLITUS, TYPE 1; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; LINKAGE (GENETICS); POLYMORPHISM, GENETIC; RUSSIA;

EID: 3042698623     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Gavrilov D.K., Kuraeva T.L., Dedov I.I., Sergeev A.S., Nosikov V.V. 1994. Frequency analysis of HLA-DQA1 and DQB1 gene alleles and susceptibility to type 1 diabetes mellitus in Russian patients. Acta Diabetologica. 31, 81-86.
2. Todd J., Bell J., McDevitt H. 1987. DQ beta gene contributes to susceptibility and resistance to IDDM. Nature. 329, 599-604.
3. Khalil I., d'Auriol L., Gobet M., Morin L., Lepage V., Deschamps I., Park M., Degos L., Galibert F., Hors J. 1990. A combination of HLA-DQ beta Asp57-negative and HLA-DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J. Clin. Invest. 85, 1315-1319.
4. Mein C.A., Esposito L., Dunn M.G., Johnson G.C., Timms A.E., Goy J.V., Smith A.N., Sebag-Montefiore L., Merriman M.E., Wilson A.J., Pritchard L.E., Cucca F., Barnett A.H., Bain S.C., Todd J.A. 1998. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nature Genet. 19, 297-300.
5. Concannon P., Gogolin-Ewens K.J., Hinds D.A., Wapelhorst B., Morrison V.A., Stirling B., Mitra M., Farmer J., Williams S.R., Cox N.J., Bell G.I., Risch N., Spielman R.S. 1998. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nature Genet. 19, 292-296.
6. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., Larrad M.T., Rios M.S., Chow C.C., Cockram C.S., Jacobs K., Mijovic C., Bain S.C., Barnett A.H., Vandewalle C.L., Schuit F., Gorus F.K., Tosi R., Pozzilli P., Todd J.A. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 5, 1075-1080.
7. Folsberg E., de Faire U., Morgenstern R. 1999. Low yield of polymorphisms from EST Blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Human Mutat. 13, 294-300.
8. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature. 414, 813-820.
9. Low P.A., Nickander K.K., Tritschler H.J. 1997. The role of oxidative stress and antioxidant in experimental diabetic neuropathy. Diabetes. 46, 38-42.
10. Shimoda-Matsubayashi S., Matsumine H., Kobayashi T., Nakagawa-Hattori, Y., Shimizu Y., Mizuno Y. 1996. Structural dimorhism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem. Biophys. Res. Commun. 226, 561-565.
11. Rosenblum J.S., Gilula N.B., Lerner R.A. 1996. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. USA. 93, 4471-4473.
12. Lemire B.D., Fankhauser C., Baker A., Schatz G. 1989. The mitochondrial targeting function of randomly generated peptide sequences correlates with predicted helical amphiphilicity. J. Biol. Chem. 264, 20206-20215.
13. Folz R.J., Peno-Green L., Grapo J.D. 1994. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum. Mol. Genet. 12, 2251-2254.
14. Sandstrom J., Nilsson P., Karlsson K., Marklund S.L. 1994. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J. Biol. Chem. 269, 19163-19166.
15. Forsberg L., Lyrenas L., de Faire U., Morgenstern R. 2001. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic. Biol. Med. 30, 500-505.
16. Palmer R.M.J., Ferrige A.G., Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327, 524-526.
17. Hall A.V., Antoniou H., Wang Y., Cheung A.H., Arbus A.M., Olson S.L., Lu W.C., Kau C.L., Marsden P.A. 1994. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J. Biol. Chem. 269, 33082-33090.
18. Xu W., Liu L., Emson P.C., Harrington C.R., Charles I.G. 1997. Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene. 204, 165-170.
19. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., Wilcken D.E.L. 1996. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med. 2, 41-45.
20. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., Nakao K., 1998. A missense Glu298-to-Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Human Genet. 103, 65-69.
21. Tsukada T., Yokoyama K., Arai T., Takemoto F., Hara S., Yamada A., Kawaguchi Y., Hosoya T., Igari J. 1998. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245, 190-193.
22. Zanchi A., Moczulski D.K., Hanna L.S., Wantman M., Warram J.H., Krolewski A.S. 2000. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 57, 405-413.
23. Boerwinkle E., Chan L. 1989. A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B (APOB) gene directly typed by the polymerase chain reaction. Nucleic Acids Res. 17, 4003.
24. Hixson I.E., Vernier D.T. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548.
25. Araki S.C., Moczulski D.K., Hanna L., Scott L.J., Warram J.H., Krolewski A.S. 2000. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes. Results of case-control and family-based studies. Diabetes. 49, 2190-2195.
26. Moczulski D.K., Rogus J.J., Antonellis A., Warram J.H., Krolewski A.S. 1998. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q. Results of a novel discordant sib-pair analysis. Diabetes. 47, 1164-1169.